For: | Takayama M, Matsui S, Kawasaki M, Asakuma Y, Sakurai T, Kashida H, Kudo M. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol 2013; 19(34): 5706-5712 [PMID: 24039365 DOI: 10.3748/wjg.v19.i34.5706] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i34/5706.htm |
Number | Citing Articles |
1 |
Bin Yan, Zhongsheng Lu, Zhizheng Ge, Side Liu, Xuegang Guo, Dean Tian, Yuxiu Yang, Xiaobo Li, Wei Gong, Zhiguo Liu, Mei Liu, Bingxi Zhou, Kabing Zhao, Fei Pan, Jing Yang, Yunsheng Yang. A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers. Clinical and Translational Gastroenterology 2019; 10(1): e00008 doi: 10.14309/ctg.0000000000000008
|
2 |
Tae-Jin Song, Jinkwon Kim, Aristeidis H. Katsanos. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study. PLOS ONE 2019; 14(5): e0216750 doi: 10.1371/journal.pone.0216750
|
3 |
V I Simanenkov, S S Vyalov. Chronic gastritis: Instructions for use of medications. Terapevticheskii arkhiv 2017; 89(8): 129 doi: 10.17116/terarkh2017898129-133
|
4 |
Meng Li, Xiaoliang Jin, Xinxin Zhou, Guochun Lou, Feng Ji, Liangjing Wang, Haifeng Jin, Xuan Huang, Jing Zhao, Haibiao Bao, Liang Huang, Changpei Shi, Bo Jin, Hanti Lu, Bin Lyu. Effectiveness and safety of a newly designed self-assembling gel in the treatment of endoscopic submucosal dissection-induced gastric ulcer: A multicenter randomized controlled trial. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1002381
|
5 |
Mikhail A. Osadchuk, Alexey M. Osadchuk. Erosive and ulcerative lesions of the digestive tract: optimization of diagnosis and management tactics. Terapevticheskii arkhiv 2022; 94(2): 271 doi: 10.26442/00403660.2022.02.201376
|
6 |
Eun-Sol Ha, Seon-Kwang Lee, Ji-Su Jeong, Woo-Yong Sim, Jun-Il Yang, Jeong-Soo Kim, Min-Soo Kim. Solvent effect and solubility modeling of rebamipide in twelve solvents at different temperatures. Journal of Molecular Liquids 2019; 288: 111041 doi: 10.1016/j.molliq.2019.111041
|
7 |
Jun Wang, Xufeng Guo, Chuncui Ye, Shijie Yu, Jixiang Zhang, Jia Song, Zhuo Cao, Jing Wang, Min Liu, Weiguo Dong. Efficacy and Safety of Proton Pump Inhibitors (PPIs) Plus Rebamipide for Endoscopic Submucosal Dissection-induced Ulcers: A Meta-analysis. Internal Medicine 2014; 53(12): 1243 doi: 10.2169/internalmedicine.53.2160
|
8 |
Tomoari Kamada, Motonori Sato, Tadashi Tokutomi, Tetsuo Watanabe, Takahisa Murao, Hiroshi Matsumoto, Noriaki Manabe, Masanori Ito, Shinji Tanaka, Kazuhiko Inoue, Akiko Shiotani, Takashi Akiyama, Jiro Hata, Ken Haruma. Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus afterHelicobacter pyloriEradication: A Multicenter Study. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/865146
|
9 |
Weiwei Li, Yunpeng Zhao, Xiangling Xu, Weiyuan Ma, Peng Gao, Yan Wang, Ke Liang, Ruifeng Li. Rebamipide suppresses TNF‐α mediated inflammation in vitro and attenuates the severity of dermatitis in mice. The FEBS Journal 2015; 282(12): 2317 doi: 10.1111/febs.13278
|
10 |
Toshihiro Nishizawa, Hidekazu Suzuki, Takanori Kanai, Naohisa Yahagi. Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis. Journal of Clinical Biochemistry and Nutrition 2015; 56(2): 85 doi: 10.3164/jcbn.14-101
|
11 |
E. P. Yakovenko, N. A. Agafonova, A. N. Ivanov, A. V. Yakovenko, M. A. Aldiyarova, T. V. Volosheinikova, Yu. V. Grigoryeva, I. P. Soluyanova. The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract. Terapevticheskii arkhiv 2016; 88(4): 88 doi: 10.17116/terarkh201688488-92
|
12 |
Eun Hye Kim, Se Woo Park, Eunwoo Nam, Jae Gon Lee, Chan Hyuk Park. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis. Surgical Endoscopy 2019; 33(4): 1271 doi: 10.1007/s00464-018-6409-4
|
13 |
Wanxin Li, Ali Farajtabar, Rong Xing, Yiting Zhu, Hongkun Zhao, Rongguan Lv. Thermodynamic solubility, solvent effect and preferential solvation analysis of rebamipide in aqueous co-solvent mixtures of propylene glycol, n-propanol, isopropanol and ethanol. The Journal of Chemical Thermodynamics 2020; 143: 106045 doi: 10.1016/j.jct.2019.106045
|
14 |
Junyuan Liu, Zhencheng Xiong, Xuhua Geng, Meihua Cui, Michael Buenor Adinortey. Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7196782
|
15 |
Rapat Pittayanon, Myriam Martel, Alan Barkun. Role of mucoprotective agents in endoscopic submucosal dissection‐derived ulcers: A systematic review. Journal of Gastroenterology and Hepatology 2018; 33(12): 1948 doi: 10.1111/jgh.14305
|
16 |
Xiangli Liu, William E. Acree, Michael H. Abraham. Descriptors for some compounds with pharmacological activity; calculation of properties. International Journal of Pharmaceutics 2022; 617: 121597 doi: 10.1016/j.ijpharm.2022.121597
|
17 |
Maidina Abuduwaili, Tomoyuki Boda, Masanori Ito, Hidehiko Takigawa, Takahiro Kotachi, Taiji Matsuo, Shiro Oka, Shinji Tanaka, Tatsuya Toyokawa. Serum Gastrin and Pepsinogen Levels after Administration of Acid Secretion Inhibitors for Ulcers due to Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/2830227
|
18 |
Mitsuhiro Fujishiro, Shuntaro Yoshida, Rie Matsuda, Akiko Narita, Hiroharu Yamashita, Yasuyuki Seto. Updated evidence on endoscopic resection of early gastric cancer from Japan. Gastric Cancer 2017; 20(S1): 39 doi: 10.1007/s10120-016-0647-8
|